The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(1,3-benzodioxol-5-yl)-3-(benzylthio)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine ID: ALA4519243
PubChem CID: 6410235
Max Phase: Preclinical
Molecular Formula: C24H18N4O3S
Molecular Weight: 442.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc(CSc2nnc3c(n2)OC(c2ccc4c(c2)OCO4)Nc2ccccc2-3)cc1
Standard InChI: InChI=1S/C24H18N4O3S/c1-2-6-15(7-3-1)13-32-24-26-23-21(27-28-24)17-8-4-5-9-18(17)25-22(31-23)16-10-11-19-20(12-16)30-14-29-19/h1-12,22,25H,13-14H2
Standard InChI Key: VQCNCZNFZABMHI-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 37 0 0 0 0 0 0 0 0999 V2000
9.3750 -5.9732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1170 -6.3397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2955 -7.1445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7728 -7.7821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9476 -7.7759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5314 -8.4863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9392 -9.2034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7677 -9.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1801 -8.4947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4370 -7.1247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6307 -6.3205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0318 -5.7526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2390 -5.9877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0484 -6.7959 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6487 -7.3603 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7653 -5.8313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5319 -6.1407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1811 -5.6319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6480 -5.0175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2940 -4.5067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0638 -4.8113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5915 -4.1731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1476 -3.4741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3458 -3.6804 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6388 -5.4207 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.8476 -5.6569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2475 -5.0899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4427 -4.2893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8434 -3.7226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0513 -3.9586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8620 -4.7666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4627 -5.3298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 1 1 0
1 2 1 0
2 3 1 0
10 5 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
16 17 2 0
17 18 1 0
18 21 2 0
20 19 2 0
19 16 1 0
2 16 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
13 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 442.50Molecular Weight (Monoisotopic): 442.1100AlogP: 5.06#Rotatable Bonds: 4Polar Surface Area: 78.39Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.69CX Basic pKa: 0.67CX LogP: 5.44CX LogD: 5.44Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -1.09
References 1. (2018) HTS Assay for Identifying Small Molecule Inhibitors of RAD52 and Uses of Identified Small Molecule Inhibitors for Treatment and Prevention of BRCA-Deficient Malignancies,